开发机器学习模型预测接受抗凝治疗的癌症相关血栓患者的出血风险
该研究在1080例癌症相关血栓患者中收集488项特征,比较CAT-BLEED评分与Lasso回归、随机森林和XGBoost算法预测出血的性能。结果显示机器学习模型在预测1至90天和1至365天出血的AUROC高于CAT-BLEED评分。这是首个用于该人群的机器学习出血预测模型,其预测性能优于传统评分。
要点
- 在1080例癌症相关血栓患者中,机器学习模型预测1至90天出血的AUROC为0.64±0.12,高于CAT-BLEED评分的0.48±0.13。
- 预测1至365天出血时,Lasso回归和XGBoost的AUROC分别为0.64±0.08和0.59±0.08,均高于CAT-BLEED评分的0.47±0.08。
- 这是首个针对接受抗凝治疗的癌症相关血栓患者的机器学习出血预测模型,其性能优于传统CAT-BLEED评分。
核心结论
- 这是首个用于接受抗凝治疗的癌症相关血栓患者的机器学习出血预测模型,其预测性能高于传统CAT-BLEED评分。
- 随着进一步开发,这一新算法可能使临床医生能够实施个性化抗凝策略以改善临床结局。
研究设计与样本
- 研究收集了1080例癌症相关血栓患者的488项特征,包括临床数据、生化指标和国际疾病分类第10版诊断。
- 研究比较了CAT-BLEED评分、Ridge和Lasso逻辑回归、随机森林和Extreme Gradient Boosting(XGBoost)算法预测静脉血栓栓塞后1至90天、1至365天和90至455天发生大出血或临床相关非大出血的性能。
主要发现
- 预测静脉血栓栓塞后1至90天大出血或临床相关非大出血时,CAT-BLEED评分的平均AUROC为0.48±0.13,Lasso逻辑回归和XGBoost均为0.64±0.12。
- 预测静脉血栓栓塞后1至365天出血时,CAT-BLEED评分的平均AUROC为0.47±0.08,Lasso逻辑回归为0.64±0.08,XGBoost为0.59±0.08。
- Lasso逻辑回归、随机森林和XGBoost在预测静脉血栓栓塞后1至90天和1至365天出血方面的性能高于CAT-BLEED评分。
临床怎么用
- 原文结论指出,随着进一步开发,这一新算法可能使临床医生能够实施个性化抗凝策略以改善临床结局。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Only 1 conventional score is available for assessing bleeding risk in patients with cancer-associated thrombosis (CAT): the CAT-BLEED score. OBJECTIVES: Our aim was to develop a machine learning-based risk assessment model for predicting bleeding in CAT and to evaluate its predictive performance in comparison to that of the CAT-BLEED score. METHODS: We collected 488 attributes (clinical data, biochemistry, and International Classification of Diseases, 10th Revision, diagnosis) in 1080 unique patients with CAT. We compared CAT-BLEED score, Ridge and Lasso logistic regression, random forest, and Extreme Gradient Boosting (XGBoost) algorithms for predicting major bleeding or clinically relevant nonmajor bleeding occurring 1 to 90 days, 1 to 365 days, and 90 to 455 days after venous thromboembolism (VTE). RESULTS: The predictive performances of Lasso logistic regression, random forest, and XGBoost were higher than that of the CAT-BLEED score in the prediction of bleeding occurring 1 to 90 days and 1 to 365 days after VTE. For predicting major bleeding or clinically relevant nonmajor bleeding 1 to 90 days after VTE, the CAT-BLEED score achieved a mean area under the receiver operating characteristic curve (AUROC) of 0.48 ± 0.13, while Lasso logistic regression and XGBoost both achieved AUROCs of 0.64 ± 0.12. For predicting bleeding 1 to 365 days after VTE, the CAT-BLEED score achieved a mean AUROC of 0.47 ± 0.08, while Lasso logistic regression and XGBoost achieved AUROCs of 0.64 ± 0.08 and 0.59 ± 0.08, respectively. CONCLUSION: This is the first machine learning-based risk model for bleeding prediction in patients with CAT receiving anticoagulation therapy. Its predictive performance was higher than that of the conventional CAT-BLEED score. With further development, this novel algorithm might enable clinicians to perform personalized anticoagulation strategies with improved clinical outcomes.
引用
- Grdinic AG, Radovanovic S, Gleditsch J, et al. Developing a machine learning model for bleeding prediction in patients with cancer-associated thrombosis receiving anticoagulation therapy. J Thromb Haemost. 2024. PMID: 38184201. doi:10.1016/j.jtha.2023.12.034
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。